Comparison of single and multiple doses of prophylactic antibiotics in experimental streptococcal

Similar documents
Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Tel: Fax:

Aminoglycoside-resistant enterococci

Determination of antibiotic sensitivities by the

Pharmacological Evaluation of Amikacin in Neonates

Antibiotic Prophylaxis Update

Principles of Antimicrobial Therapy

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

Introduction to Pharmacokinetics and Pharmacodynamics

Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci

Management of Native Valve

against Clinical Isolates of Gram-Positive Bacteria

Factors affecting plate assay of gentamicin

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Persistent in Kidneys

An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus

JAC Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Prophylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi

Principles of Antimicrobial therapy

Evaluation of MicroScan MIC Panels for Detection of

Open Access. The Open Microbiology Journal, 2008, 2,

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

Y-688, a New Quinolone Active against Quinolone-Resistant Staphylococcus aureus: Lack of In Vivo Efficacy in Experimental Endocarditis

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Defining Resistance and Susceptibility: What S, I, and R Mean to You

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

Effect of Gentamicin Dosing Interval on Therapy of Viridans Streptococcal Experimental Endocarditis with Gentamicin plus Penicillin

Discrepancy Between Carbenicillin and Ampicillin Activities Against Enterococci and Listeria

J. W. Mouton, H. P. Endtz, J. G. den Hollander, N. van den Braak and H. A. Verbrugh

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Received 13 April 2003; returned 27 October 2003, revised 15 November 2003; accepted 17 November 2003

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys

Antimicrobial Pharmacodynamics

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Studies on Antibiotic Synergism Against Enterococci

Effeet on Bacterial Growth

Considerations for antibiotic therapy. Christoph K. Naber Interventional Cardiology Heartcenter - Elisabeth Hospital Essen

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

by adding different antibiotics to sera containing

Prevention of Pyelonephritis Due to Escherichia coli in Rats with Gentamicin Stored in Kidney Tissue

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

Baytril 100 (enrofloxacin) Injectable is FDA-approved for BRD control (metaphylaxis) in high-risk cattle.

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE. J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE and G. H.

Visit ABLE on the Web at:

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Pharmacology Week 6 ANTIMICROBIAL AGENTS

number Done by Corrected by Doctor Dr.Malik

Antibacterial susceptibility testing

Influence of Inflammation on the Efficacy of Antibiotic Treatment of Experimental Pyelonephritis

Should we test Clostridium difficile for antimicrobial resistance? by author

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring. Janis Chan Pharmacist, UCH 2008

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Jan A. Jacobs* and Ellen E. Stobberingh

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method

Doxycycline for enterococcus

Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

Methods for the determination of susceptibility of bacteria to antimicrobial agents., Terminology

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Comparison of Daptomycin, Vancomycin, and Ampicillin-

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Other Beta - lactam Antibiotics

The Turkish Journal of Pediatrics 2008; 50:

The impact of the pre-treatment interval on antimicrobial efficacy in a biological model

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

Bactericidal and Bacteriostatic Action of Chloramphenicol

GARY WOODNUTT* AND VALERIE BERRY SmithKline Beecham Pharmaceuticals, Collegeville, Pennsylvania

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli

Microbiology, University of Zürich, Switzerland

Impact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model

ECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD

with Other Orally Administered Drugs

IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA

Measure Information Form

Improved Susceptibility Disk Assay Method Employing an

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

American Association of Feline Practitioners American Animal Hospital Association

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Teicoplanin and Vancomycin for Treatment of Experimental

Transcription:

LBORTORY INVESTIGTION ENDOCRDITIS Comparison of single and multiple doses of prophylactic antibiotics in experimental streptococcal endocarditis RFFELE MLINVERNI, M.D., PTRICK B. FRNCIOLI, M.D., ND MICHEL P. GLUSER, M.D. Downloaded from http://ahajournals.org by on October 9, 218 BSTRCT Single-doses or short-term administration of /3-lactam antibiotics alone or combined with aminoglucoside antibiotics have failed to consistently prevent experimental streptococcal endocarditis induced by high inocula of bacteria poorly susceptible to killing by these antibiotics. The optimal duration of administration of antibiotics for successful prophylaxis under these circumstances has not been established. We therefore tested, in rats with catheter-induced sterile aortic vegetations, the duration of administration of antibiotic necessary to prevent endocarditis induced by bacterial inocula 1 to 1, times the 9% infective dose of two tolerant viridans-group streptococci and two Streptococcusfaecalis strains. Multiple-dose regimens of amoxicillin alone or of amoxicillin combined with gentamicin were studied. gainst the two viridans group streptococci, successful prophylaxis was achieved with multiple doses of amoxicillin alone given over 24 to 48 hr and by the combination of amoxicillin and gentamicin given for 6 to 24 hr. gainst the two S. faecalis strains, multiple-dose regimens with amoxicillin alone failed, but the combination of amoxicillin and gentamicin was successful when administered for 48 to 72 hr. Thus, after challenge with high bacterial inocula, repeated doses of a,f-lactam antibiotic alone were sufficient to prevent viridans streptococcal endocarditis, but multiple doses of a bactericidal combination (,3-lactam plus aminoglucoside), as necessary for the treatment of established endocarditis, were a prerequisite for successful prophylaxis of S. faecalis endocarditis. Circulation 76, No. 2, 376-382, 1987. STUDIES ON THE PREVENTION of streptococcal endocarditis both in rabbits and in rats have demonstrated that prophylaxis can be successfully achieved with a single dose of cell wall-active antibiotics or of bacteriostatic antibiotics such as clindamycin and erythromycin. 1-5 However, this protection was limited to the minimum bacterial inoculum infecting 9% of untreated animals (ID9) when the test streptococcal strain was not killed by the antibiotic.4 6 In contrast, when the test streptococcus was rapidly killed, protection was afforded even after challenge with inocula exceeding by far the ID9.4 Since the majority of viridans streptococci and virtually all strains of Streptococcusfaecalis isolated from patients with endocarditis7-9 are poorly susceptible to bacterial killing by cell From the Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne. Supported by grant No. 3.847.83 of The Swiss Foundation for Scientific Research. ddress for correspondence: Dr. M. P. Glauser, Division of Infectious Diseases, CHUV - 111 Lausanne. Switzerland (21/41.46.84). Received Dec. 23, 1986; revision accepted pril 23. 1987. Presented in abstract form at the 23rd Interscience Conference on ntimicrobial gents and Chemotherapy, Las Vegas, 1983. 376 wall-active antibiotics, single-dose prophylaxis of experimental endocarditis due to these strains has shown limited efficacy.4 6 Recent experiments investigating the mode of action of prophylactic antibiotics in the absence of bacterial killing in rats have suggested that the prolonged inhibition of bacterial growth might be an important mechanism of protection, allowing the resting organisms that have seeded the vegetations to be cleared before growth starts. In these experiments, repeated administration of antibiotics, providing prolonged serum inhibitory activity, permitted the circumvention of the limited efficacy of single-dose prophylaxis that is observed with inocula greater than the ID9 1 Most recent recommendations on the prevention of bacterial endocarditis in humans have advocated single-dose or short-term (one additional dose after 6 hr) prophylaxis.' 1212 However, most failures have been observed after single-dose or short-term prophylaxis. 13 This might simply be due to the fact that these regimens are those in common use, but is possibly also due to the magnitude of the bacterial inoculum size. 14 The purpose of the present study was to investigate whether CIRCULTION

Downloaded from http://ahajournals.org by on October 9, 218 multiple doses of amoxicillin alone or of the combination of amoxicillin plus gentamicin would successfully prevent streptococcal endocarditis after challenge with high bacterial inocula, a condition in which single doses of amoxicillin alone or the combination of amoxicillin plus gentamicin have failed.4 6 Materials and Methods Microorganisms. Four streptococcal strains, two viridans streptococci (Streptococcus sanguis and Streptococcus intermedius) and two S. faecalis strains (S. faecalis 39 and S. faecalis 129) were used in the present experiments. The strains have been previously used in experimental endocarditis in rats4' 6 and in rabbits.2 5 Determination of minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), and rates of killing. The MICs of amoxicillin and of gentamicin for the four test strains were determined by a standard broth dilution technique with an inoculum of 15 organisms from an overnight culture. 15 The MBCs were determined by subculturing, on penicillinase-containing (Difco Laboratories, Detroit) blood agar plates, 1-fold and 1-fold dilutions of a.1 ml sample from each dilution of antibiotic showing no turbidity after 18 hr of incubation. fter incubation for 48 hr, the number of colonies from each subculture on blood agar plates was counted and the MBC was determined as the lowest dilution of antibiotic that showed 99.9% killing. With the use of concentrations of 25 gg amoxicillin per milliliter (Beecham Research Laboratories, Brentford, England), of 8,ug gentamicin per milliliter (Schering Corporation, Kenilworth, NJ), or of both, the rates of killing of the four strains were determined in tryptic soya broth (TSB, Difco Laboratories) with a 16 inoculum from an overnight culture. These concentrations of amoxicillin and gentamicin were chosen because they were similar to peak serum levels obtained in rats 3 min after the injection of 4 mg/kg iv amoxicillin and of 4 mg/kg im gentamicin. In man, these serum levels are achieved 2 hr after an oral dose of 3 g of amoxicillin'6 and 3 min after an intravenous dose of 1.5 mg/kg of gentamicin. 17 t various times after the inoculation of the bacteria into the antibiotic containing broth, 1-, 1-3, and 1-5 dilutions of a. 1 ml sample were subcultured on penicillinase-containing blood agar plates and incubated for 48 hr for colony counts. Serum levels of antibiotics and determination of the serum bactericidal activity. Serum levels of antibiotics were determined 3 min and 1, 2, and 4 hr after the injection of 4 mg/kg iv amoxicillin or 4 mg/kg im gentamicin into groups of five rats by a standard agar diffusion technique. Bacillus subtilis was used as the test organism and normal rat serum was used as the diluent. 18 The serum bactericidal activity 3 min, 1, 2 and 4 hr after the administration of amoxicillin (or of the combination of amoxicillin plus gentamicin) to rats was determined for each of the four strains by standard methods with use of an inoculum of 15 colony-forming units (cfu) from an overnight culture.'9 The serum bactericidal activity was defined as the highest serum dilution providing 99.9% killing of the initial inoculum after 18 hr of incubation. Production of endocarditis and natural history of infection. Sterile vegetations were produced in female Wistar rats (18 to 2 g) by a modification of a previously described method.2 In brief, a polyethylene catheter (PP 1, Portex, Hythe, Kent, England) was inserted through the right carotid artery across the aortic valve and secured with a silk ligature. Twenty-four hours after catheterization, rats were injected via the tail vein with.5 ml of saline containing 18 cfu from an LBORTORY INVESTIGTION-ENDOCRDITIS overnight culture of the test organisms. The number of bacteria injected intravenously was adjusted by counting the organisms in an hemocytometer, confirmed by colony counts and expressed in colony-forming units per milliliter. The ID9% was 16 cfu/ml for S. sanguis, 15 cfu/ml for S. intermedius, and 14 cfu/ml for both S. faecalis strains. Thus, the 18 cfulml inoculum size used in the prophylaxis experiments was 1 times the ID9 for S. sanguis, 1 times the ID9 for S. intermedius, and 1, times the ID9 for both S. faecalis strains. Rats were killed 72 hr after single-dose prophylaxis and 5 days after the last dose of drug when multiple doses of antibiotic(s) were given. The aortic vegetations were excised, weighed, homogenized in 1 ml of saline, serially diluted, and plated on penicillinase-containing blood agar plates. The colonies were counted after 24 and 48 hr of incubation at 37 C. This method permitted the detection of 12 cfu/g of vegetation. Prophylaxis of endocarditis with amoxicillin and with amoxicillin plus gentamicin. In each experiment with one of the four test strains, amoxicillin was given at a dose of 4 mg/kg iv and gentamicin at a dose of 4 mg/kg im. The control groups were given intravenous saline. Depending on the strain tested, the following prophylactic regimens, including either amoxicillin alone or combined amoxicillin plus gentamicin, were tested: (1) single-dose antibiotic prophylaxis 3 min before bacterial challenge, (2) antibiotic prophylaxis 3 min before bacterial challenge, followed 6 hr later by one additional dose of antibiotic (alone or combined), (3) antibiotic prophylaxis 3 min before bacterial challenge, followed by four additional doses at 6 hr intervals (providing antibiotic serum levels for 28 to 3 hr), by six additional doses (providing serum levels for 4 to 42 hr), by eight additional doses (providing serum levels for 52 to 54 hr), or by 12 additional doses (providing antibiotic serum levels for 76 to 78 hr). Statistical evaluation. For each strain, the incidence of endocarditis in the prophylaxis groups was compared with the incidence in the control group by the chi-square test with the Yates correction. Results MICs and MBCs. The MICs and MBCs of amoxicillin and gentamicin for the four test strains are listed in table 1. ll strains had high MBC values, a phenomenon that is common among streptococci when careful measures to avoid the antibiotic carryover are taken.7' 8 ntibiotic serum levels in rats. The amoxicillin serum levels (mean ± SD levels of five rats at each time interval) after the intravenous injection of 4 mg/kg amoxicillin were 23.7 + 3,ug/ml at 3 min, 8.8 + 1 gg/ml at 1 hr, 3.5 ±.4,ug/ml at 2 hr,.6 ±.3 TBLE 1 MICs and MBCs of amoxicillin and gentamicin (gg/ml) moxicillin Gentamicin Strain MIC MBC MIC MBC S. sanguis.16 32 8 32 S. intermedius.125 128 1 2 S. faecalis 39 1 128 32 64 S. faecalis 129 1 128 4 16 Vol. 76, No. 2, ugust 1987 377

MLINVERNI et al.,g/ml at 4 hr, and undetectable at 6 hr. The mean (-+ SD) gentamicin serum levels (p.g/ml; in five rats at each time interval) after the intramuscular injection of 4 mg/kg gentamicin were 8 + 2.1 at 3 min, 4.6 + 1. 8 at 1 hr, 1.9 +.9 at 2 hr, and undetectable at 4 hr. Serum bactericidal activity (SB). fter the intravenous injection of 4 mg/kg of amoxicillin to rats, no SB (in five animals) against any of the four streptococcal strains could be detected 3 min or later after injection. fter the administration of combined amoxicillin plus gentamicin (4 mg/kg), the SBs against both viridans streptococci were 1:4 at 3 min, 1: 2 at 2 hr, and undetectable at 4 hr. gainst both S. faecalis strains, the SBs of combined amoxicillin plus gentamicin were 1: 8 at 3 min, 1:4 at 2 hr, and undetectable at 4 hr. Rates of killing of the four test strains. Figure 1 shows the rates of killing of the four test strains by 25,ug/ml amoxicillin with and without the addition of 8,vg/ml gentamicin. With concentrations of 8,g/ml of gentamicin alone, all four test strains showed survival of 1% or more of the initial inoculum after 24 hr of incubation (not shown). S. sanguis and S. intermedius were killed by peak concentrations of amoxicillin within 24 hr and 48 hr of incubation, respectively. Neither S. faecalis strains exhibited a significant decrease of colony counts within 48 hr of exposure to peak amoxicillin concentrations. When exposed to the combination of amoxicillin plus gentamicin at peak concentrations, killing of more than 99.9% of the original inoculum of all four test strains was achieved within 6 hr, thus demonstrating synergism on exposure to this combination. ntibiotic prophylaxis of S. sanguis and S. intermedius endocarditis. The results obtained with the different prophylactic regimens against each of the two viridans streptococci are shown in figure 2. Regimens with amoxicillin alone. Single-dose amoxicillin was ineffective for prophylaxis against endocarditis induced by 18 cfu of either viridans streptococci. Four subsequent doses of amoxicillin completely prevented S. sanguis endocarditis, but failed to protect against 1 Downloaded from http://ahajournals.org by on October 9, 218 E h-. m U. CD 5) _J 71 61 51 l 3 21 2 6 12 24 48 Hours of Incubation FIGURE 1. Rates of killing in vitro of four streptococcal strains (1 = S. sanguis; 2 = S. intermedius; 3 = S. faecalis 39; 4 = S. faecalis 129) incubated in 25,ug/ml of amoxicillin alone (open triangles) or in the combination of 25 gg/ml of amoxicillin plus 8,ug/ml of gentamicin (open squares). The rates of killing of the four test strains by 8,ug/ml of gentamicin alone are not shown, but all four test strains showed 1% survival of the inoculum at 24 hr. The closed circles represent control strains in tryptic soya broth. 378 CIRCULTION

Downloaded from http://ahajournals.org by on October 9, 218 11 c 8 > 6 @ 4 1 C 21 Ce._ c ;_ C) ) cc V I 11 1l1 81 61 41 21 o Prophylactic dose Subsequent doses -C 24 S.Sanguis 1 S.Intermedius 13 ND ~~~~~ ~~~~~ 13 15 E1611~ - 1 1 1 _ - 4 8 * G 2 ND *~~ 1 1 1-1 4 FIGURE 2. Incidence of endocarditis in control (C) rats and in rats given amoxicillin () or the combination of amoxicillin plus gentamicin (G) prophylaxis after challenge with two viridans streptococcal strains, S. sanguis (top) and S. intermedius (bottom). The bacterial inoculum used for challenge (18 cfu) represented 1 (S. sanguis) to 1 times (S. intermedius) the ID9% of the two strains. The total number of rats per group is indicated at the base of each column. The number of subsequent doses administered after the prophylactic dose is indicated under each column, at the base of the figure. ND = not tested for that strain. p values were calculated by comparing the incidence of endocarditis after the various prophylactic regimens with that in controls with the use of chi-square analysis with the Yates correction. The cross symbolizes p < 1-2; the asterisk symbolizes p < 1-5. endocarditis induced by S. intermedius. Indeed, eight subsequent doses of amoxicillin had to be administered after challenge with the latter strain to successfully prevent endocarditis. Regimens with the combination of amoxicillin plus gentamicin. The combination given as a single dose failed to consistently protect against endocarditis due to either of the viridans streptococci. gainst challenge with S. sanguis, however, a single dose of amoxicillin + gentamicin was slightly more effective than it was against S. intermedius. Indeed, one subsequent dose of amoxicillin + gentamicin completely prevented S. sanguis endocarditis, while four subsequent doses of the combination were required to significantly protect the animals from S. intermedius infection. ntibiotic prophylaxis of S. faecalis 39 and S. faecalis Vol. 76, No. 2, ugust 1987 LBORTORY INVESTIGTION-ENDOCRDITIS 129 endocarditis. The results obtained with the different prophylactic regimens against each of the 2 S. faecalis strains are shown in figure 3. Regimens with amoxicillin alone. Single-dose amoxicillin failed to protect against endocarditis due to either S. faecalis strains. Eight subsequent doses of the drug had to be given to significantly protect against S. faecalis 39 (p =.3 when compared with controls), but a failure rate of 23% was still observed. gainst S. faecalis 129, eight doses of amoxicillin alone totally failed to prevent endocarditis. Regimens with the combination of amoxicillin plus gentamicin. Single-dose amoxicillin + gentamicin failed to prevent endocardits due to either S. faecalis strains. Four subsequent doses of amoxicillin + gentamicin significantly protected against S. faecalis 39 endocarditis (p =.1 when compared with controls), but the failure rate of 36% was high, while six subsequent doses of amoxicillin + gentamicin completely protected the animals. fter challenge with S. faecalis v) c a) E- 'S 11 81 61 4 2' a, 1w X 8 ~I _ 6 6 j 2 1 Prophylactic dose Subsequent doses I -Ul 11 21 T...,.....',. :.:.:....,.'.........:,:. 5.:.:, :: :: :: :*: ::,:,:, S. Faecalis 39 ;.,;,:,:, ::...... :: :.: :,... 1. *:-:, -: 8 ND S. Faecalis 129 4 [. 17 8 ND 4 G 2 ND ND ND 6 + 8 * G 11 FIGURE 3. Incidence of endocarditis in control (C) rats and in rats given amoxicillin () or the combination of amoxicillin plus gentamicin (G) prophylaxis after challenge with two S. faecalis strains. The bacterial inoculum used for challenge (18 cfu) represented 1, times the ID9 of both strains. The total number of rats in each group is indicated at the base of each column. The number of the multiple (subsequent) doses of antibiotic(s) administered after the prophylactic dose is indicated under each column, at the base of the figure. ND = regimen not tested for that strain. p values were calculated by comparing the incidence of endocarditis after the various prophylactic regimens with that in controls with the use of chi-square analysis with the Yates correction. The cross symbolizes p < 1-2, the asterisk p < 1-5. 12 379

Downloaded from http://ahajournals.org by on October 9, 218 MLINVERNI et al. 129, even eight subsequent doses of the combination resulted in a high failure rate (36%); endocarditis induced by this strain could only be successfully prevented by 12 subsequent doses of amoxicillin + gentamicin. Discussion Previous studies in rats have shown that successful prophylaxis of streptococcal endocarditis depends both on the susceptibility of the test strain to killing by the antibiotic and on the bacterial inoculum size used for challenge. When bacteria are rapidly killed by the antibiotic, single-dose prophylaxis is successful irrespective of the number of organisms used to induce endocarditis, and therefore provides a wide margin of efficacy.4 In contrast, against the so-called tolerant strains (a group that includes most viridans streptococcal strains isolated from the mouth flora21 and from patients with endocarditis7' 8), cell wall-active antibiotics as well as bacteriostatic antibiotics such as clindamycin and erythromycin have only prevented endocarditis induced by the ID9, but have not prevented endocarditis induced by higher bacterial numbers. 3 4 6 1, 21 Recent experiments in rats have suggested that the prolonged inhibition of bacterial growth, as provided by repeated administration of antibiotics after a prophylactic dose, might circumvent the limited efficacy of single-dose antibiotic prophylaxis.' The present results confirm our previous observations that single-dose prophylaxis with amoxicillin alone, or with the combination of amoxicillin plus gentamicin, does not reliably prevent streptococcal endocarditis induced by high bacterial numbers.6 In addition, the results clarify the conditions necessary for inoculum-independent successful antibiotic prophylaxis of both viridans streptococcal and enterococcal (S. faecalis) endocarditis. With regard to viridans streptococcal endocarditis, the results show that amoxicillin alone administered every 6 hr for 24 to 48 hr after bacterial challenge prevented endocarditis induced by inoculum sizes from 1 to 1 times the ID9 of the test strains. The combination of amoxicillin plus gentamicin significantly reduced the need for additional drug administration. With regard to the prophylaxis of enterococcal endocarditis, in contrast to viridans streptococcal endocarditis, the prolonged administration of amoxicillin alone for 48 hr after challenge failed to reliably prevent the infection, since this regimen was unsuccessful against one of the two S. faecalis strains tested. These 38 differences in the efficacy of antibiotic prophylaxis against viridans and enterococcal endocarditis might be partly related to the higher bacterial inocula relative to the ID9 of the S. faecalis strains when compared with the inocula of two viridans streptococci. However, similar observations regarding the prophylaxis of S. faecalis endocarditis were made by Durack et al.22 and Guze et al.,23 who used inocula of 16 to 17 S. faecalis cfu/ml that caused a 1% infection rate in controls. s in the present study, these authors not only found that single-dose ampicillin prophylaxis failed to prevent S. faecalis endocarditis, but also that two to five subsequent doses of ampicillin alone as well as two to three subsequent doses of the combination of ampicillin plus gentamicin did not consistently prevent endocarditis. More prolonged prophylactic regimens were not tested in these experiments. In the present experiments, when amoxicillin plus gentamicin was administered for the prevention of enterococcal endocarditis, successful prophylaxis was achieved if the combination was given for 36 or 72 hr. Thus, as was observed after challenge with the two viridans streptococcal strains, against enterococcal endocarditis the combined /3-lactam plus aminoglucoside regimens were superior to the regimens including a /3-lactam alone. The exact mechanisms by which the multiple-dose antibiotic regimens were successful in preventing endocarditis after challenge with high bacterial inocula are unknown. Previous observations have indicated that the number of bacteria adhering to the vegetations after challenge is related to the magnitude of the inoculum size used for challenge. When high inocula were used, sustained bacteriostatic blood levels were required to successfully prevent endocarditis due to tolerant organisms, probably by allowing all adherent organisms to be cleared from the vegetations.' It is conceivable that a similar mechanism operated in the present experiments (against viridans streptococci) after prophylaxis with amoxicillin alone. On the other hand, the fact that multiple doses of the combination of amoxicillin plus gentamicin were clearly more effective than amoxicillin alone suggests that this combination operated, at least partially, through a killing mechanism. Moreover, it was striking that for the prevention of S. faecalis endocarditis, only the combined amoxicillin plus gentamicin regimen was consistently successful. Such combinations are required to produce a bactericidal effect on enterococci, which are notoriously insensitive to bacterial killing by most cell wall-active antibiotics.' Only a few studies have compared the efficacy of single versus multiple doses of antibiotics in relation to CIRCULTION

Downloaded from http://ahajournals.org by on October 9, 218 the bacterial inoculum sizes used for challenge. In early experiments in rabbits, Durack et al.' used a bacterial inoculum size of 11 cfu of a S. sanguis strain that resulted in a 1% infection rate in controls. This inoculum probably represented from 1 to 1 times the ID9 for that organism.5 In these experiments, only multiple doses of penicillin G and of penicillin V, as well as a large single dose of procaine penicillin or of the combination of penicillin G and benzathin penicillin (providing serum inhibitory levels for at least 24 hr after challenge) were effective in the prevention of S. sanguis endocarditis. With regard to S. faecalis infection, as previously mentioned, from one to five doses of ampicillin or two to three doses of ampicillin plus gentamicin failed to reliably prevent enterococcal endocarditis.22' 23 Thus, previous experiments in rabbits, as well as our present studies in rats, suggest that multiple dose regimens are necessary for the prevention of experimental streptococcal endocarditis induced by high bacterial numbers. The clinical relevance of data derived from the animal preparation of endocarditis to patients has been questioned, mainly on the grounds that the bacterial numbers used to induce experimental endocarditis exceeded by far those detected in the blood of patients undergoing dental or urogenital procedures. It should be pointed out, however, that the number of bacteria circulating after intravenous bacterial injections into animals is several logs less than the total number of bacteria injected.' For instance, after the intravenous injection of 14 S. faecalis 129 (an inoculum size that corresponds to the ID9 for this strain), a mean of 12 bacteria/ml of blood was found in the heart blood of five rats at 2 min after injection, and S. faecalis colonies were barely detectable 15 min after injection.* More importantly, our recent studies on the production of endocarditis in rats after the extraction of periodontally diseased teeth have failed to demonstrate a relationship between the total number of a given streptococcal species circulating immediately after tooth extraction and the likelihood of these streptococci to subsequently produce endocarditis.24 The number of bacteria circulating and their stickiness is not known in those very few patients who are going to develop endocarditis. More importantly,there are groups of patients who are at particularly high risk of developing endocarditis after bacteremic episodes. Since our present understanding of the mode of action of prophylactic antibiotics indicates that prolonged antibiotic levels are required to provide the best margin *Moreillon P, Malinvemi R, Glauser MP: Unpublished observation. Vol. 76, No. 2, ugust 1987 LBORTORY INVESTIGTION-ENDOCRDITIS of safety for the prevention of endocarditis, the Swiss recommendations for the prophylaxis of endocarditis,25 unlike the British recommendations" and the most recent recommendations of the merican Heart ssociation,'2 suggest that multiple-dose regimens administered over 48 hr should be used for the prophylaxis of endocarditis in high-risk subjects. Cost-benefit estimates will need to be made of the potential impact of such prophylactic multiple-dose regimens. We thank Josd Entenza for excellent technical assistance and Sylviane Bovey for typing the manuscript. References 1. Bernard JP, Francioli P, Glauser MP: Vancomycin prophylaxis of experimental Streptococcus sanguis endocarditis: inhibition of bacterial adherence rather than bacterial killing. J Clin Invest 68: 1113, 1981 2. Durack DT, Petersdorf RG: Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest 52: 592, 1973 3. Glauser MP, Francioli P: Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis 146: 86, 1982 4. Glauser MP, Bernard JP, Moreillon P, Francioli P: Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis 147: 568, 1983 5. Pelletier LL Jr, Durack DT, Petersdorf RG: Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest 56: 319, 1975 6. Francioli P, Moreillon P, Glauser MP: Comparison of single doses of amoxicillin or amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcusfaecalis and by viridans streptococci. J Infect Dis 152: 83, 1985 7. Glauser MP, Francioli P, Meylan P, Moreillon P, Heraief E: ntibiotic prophylaxis for patients with prosthetic valves. Lancet 1: 237, 1983 8. Meylan PR, Francioli P, Glauser MP: Discrepancies between minimal bactericidal concentrations and actual killing of viridans streptococci by cell-wall active antibiotics. ntimicrob gents Chemother 28: 418, 1986 9. Moellering RC, Krogstad DJ: ntibiotic resistance in enterococci. In Schlesinger D, editor: Microbiology. Washington DC, 1979, merican Society for Microbiology, p 293 1. Moreillon P, Francioli P, Overholser D, Meylan P, Glauser MP: Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius. J Infect Dis 154: 81, 1986 11. Simmons N, Cawson R, Clarke C, Eykin SJ, Mc Gowan D, Oakley CM, Shanson DC: The antibiotic prophylaxis of infective endocarditis. Lancet 2: 568, 1982 12. Shulman ST, mren BP, Bisno L, Dajani S, Durack DT, Gerber M, Kaplan EL, Millard HD, Sanders WE, Schwartz RH, Watanakunakorn W: Prevention of bacterial endocarditis. statement for health professionals by the committee on rheumatic fever and infective endocarditis of the council on cardiovascular disease in the young. Circulation 7: 1123, 1984 13. Durack DT, Kaplan EL, Bisno L: pparent failures of endocarditis prophylaxis. nalysis of 52 cases submitted to a National Registry. JM 25: 2318, 1983 14. Denning DW, Cassidy M, Dougall, Hillis WS. Failure of single dose amoxicillin as prophylaxis against endocarditis. Br Med J 289: 1499, 1984 15. Jones RN, Barry L, Gavan TL, Washington J II: Susceptibility tests: Microdilution and macrodilution broth procedures. In Lennette EH, Balows, Hausler WJ Jr, Shadomy HJ, editors: Manual of clinical microbiology, ed 4. Washington, DC, 1985, merican Society for Microbiology, p 972 381

MLINVERNI et al. 16. Shanson DC, shford RF, Singh J: High-dose oral amoxicillin for preventing endocarditis. Br Med J 1: 445, 198 17. Siber GR, Echevarria P, Smith L, Paisley JW, Smith DH: Pharmacokinetics of gentamicin in children and adults. J Infect Dis 132: 637, 1975 18. nhalt JP: ssays for antimicrobial agents in body fluid. In Lennette EH, Balows, Hausler WJ Jr, Shadomy HJ, editors: Manual of clinical microbiology, ed 4. Washington. DC, 1985, merican Society for Microbiology, p 19 19. Schoenknecht FD, Sabath LD, Thomsberry C. Susceptibility tests: special tests. In Lennette EH, Balows, Hausler WJ Jr, Shadomy HJ, editors: Manual of clinical microbiology, ed 4. Washington, DC, 1985, merican Society for Microbiology, p 1 2. Heraief E, Glauser MP, Freedman LR: Vancomycin prophylaxis of streptococcal endocarditis in rats. In Nelson JD, Grassi C, editors: Current chemotherapy and infectious disease. Washington. DC, 198, merican Society for Microbiology, vol II, p 911 21. Hess J, Holloway Y, Dankert J: Penicillin prophylaxis in children with cardiac disease: postextraction bacteremia and penicillin-resistant strains of viridans streptococci. J Infect Dis 147: 133, 1983 22. Durack DT, Starkebaum MK, Petersdorf RG: Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis. J Lab Clin Med 9: 171, 1977 23. Guze P, Kalmanson GM, Freedman LR, Ishida K, Guze LB: ntibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits. ntimicrob gents Chemother 24: 514, 1983 24. Overholser CD, Moreillon P, Glauser MP: Experimental bacterial endocarditis after dental extractions in rats with periodontitis. J Infect Dis 155: 17, 1987 25. Malinverni R, Francioli P, Gerber, Glauser MP, Hirschel B, Luithy R, Mombelli G, Regamey C, Schaad UB, Schadelin J, Stalder H, Zimmerli W: Prophylaxis of bacterial endocarditis. Recommendations of the Swiss Working group on prevention of bacterial endocarditis. Schweiz Med Wochenschr 114: 1246, 1984 Downloaded from http://ahajournals.org by on October 9, 218 382 CIRCULTION